Ultra-Low Dose Oral Naltrexone Decreases Side Effects and Potentiates the Effect of Methadone
- 1 June 2003
- journal article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 25 (6) , 491-494
- https://doi.org/10.1016/s0885-3924(03)00139-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1XBiochemical and Biophysical Research Communications, 2003
- The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative periodPain, 2002
- Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liabilityPain, 2000
- NMDA-Receptor Antagonists in Neuropathic Pain: Experimental Methods to Clinical TrialsJournal of Pain and Symptom Management, 2000
- Opioid-sparing Effects of a Low-dose Infusion of Naloxone in Patient-administered Morphine SulfateAnesthesiology, 1997
- Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in ratsPain, 1996
- The NMDA Receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioidsPain, 1994
- Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801Science, 1991
- Opioids can evoke direct receptor-mediated excitatory effects on sensory neuronsTrends in Pharmacological Sciences, 1990